Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Dietz

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Nature Cardiovascular Research|July 24, 2023
Loss of soluble guanylyl cyclase in platelets contributes to atherosclerotic plaque formation and vascular inflammationCarina Mauersberger, Hendrik B Sager, Jana Wobst, et al.
Journal of Medicinal Chemistry|September 24, 2020
Potent and Selective Human Prostaglandin F (FP) Receptor Antagonist (BAY-6672) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)Hartmut Beck, Tobias Thaler, Daniel Meibom, et al.
Respiratory Research|October 1, 2022
Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGCEva M Becker-Pelster, Michael G Hahn, Martina Delbeck, et al.
Bioconjugate Chemistry|June 6, 2022
A Novel NAMPT Inhibitor-Based Antibody-Drug Conjugate Payload Class for Cancer TherapyNiels Böhnke, Markus Berger, Nils Griebenow, et al.
Journal of Medicinal Chemistry|April 19, 2021
Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY 1101042)Michael G Hahn, Thomas Lampe, Sherif El Sheikh, et al.
Gut|May 28, 2026
The endogenous peptide GPR15L shapes the intestinal microbiota to counteract colitisMiriana Leggio, Sebastian Schramm, Lisa Dietz, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Nature Cardiovascular Research|July 24, 2023
Loss of soluble guanylyl cyclase in platelets contributes to atherosclerotic plaque formation and vascular inflammationCarina Mauersberger, Hendrik B Sager, Jana Wobst, et al.
Journal of Medicinal Chemistry|September 24, 2020
Potent and Selective Human Prostaglandin F (FP) Receptor Antagonist (BAY-6672) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)Hartmut Beck, Tobias Thaler, Daniel Meibom, et al.
Respiratory Research|October 1, 2022
Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGCEva M Becker-Pelster, Michael G Hahn, Martina Delbeck, et al.
Bioconjugate Chemistry|June 6, 2022
A Novel NAMPT Inhibitor-Based Antibody-Drug Conjugate Payload Class for Cancer TherapyNiels Böhnke, Markus Berger, Nils Griebenow, et al.
Journal of Medicinal Chemistry|April 19, 2021
Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY 1101042)Michael G Hahn, Thomas Lampe, Sherif El Sheikh, et al.
Gut|May 28, 2026
The endogenous peptide GPR15L shapes the intestinal microbiota to counteract colitisMiriana Leggio, Sebastian Schramm, Lisa Dietz, et al.
Pageof 4